IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS)

Clinical trials for IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS) explained in plain language.

Never miss a new study

Get alerted when new IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS) trials appear

Sign up with your email to follow new studies for IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2

Off-the-Shelf immune cell therapy tested for multiple autoimmune diseases

Disease control Recruiting now

This study is testing whether adding a new type of immune cell therapy (called AlloNK) to an existing drug (rituximab) can better control several autoimmune diseases that have come back after standard treatments. The trial will enroll 90 adults with rheumatoid arthritis, Sjögren'…

Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS)

Phase: PHASE2 • Sponsor: Artiva Biotherapeutics, Inc. • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS)

Get alerted when new IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS) trials appear

Off-the-Shelf immune cell therapy tested for multiple autoimmune diseases